Skvarka Jan Insider Trades

Insider Trading History

Track insider trading activity for Skvarka Jan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $802k 207,154 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.4k 57,603 shares
$1.50
$3.87
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $533k 30,700 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 30,700 shares
$4.91
$17.36
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $579k 149,551 shares
Last Trade
Jan 31, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$103k 60,000 shares
$1.72
$3.87
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $347k 89,551 shares
Last Trade
Jun 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$198k 41,581 shares
$4.75
$3.87
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $384k 22,100 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.9k 22,100 shares
$4.16
$17.36
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $186k 47,970 shares
Last Trade
Sep 11, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$125k 5,000 shares
$25.05
$3.87
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $205k 52,970 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$452k 16,364 shares
$27.62
$3.87
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $356k 20,500 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$135k 20,500 shares
$6.59
$17.36
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $712k 41,000 shares
Last Trade
Mar 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$302k 41,000 shares
$7.36
$17.36
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $142k 36,606 shares
Last Trade
Sep 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.09M 36,606 shares
$29.73
$3.87
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $0 0 shares
Last Trade
Nov 17, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$36.1M 1,959,500 shares
$18.44
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $0 0 shares
Last Trade
May 12, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$220k 23,802 shares
$9.24
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $3.91M 197,000 shares
Last Trade
May 12, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$214k 23,802 shares
$9.00
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $473k 23,802 shares
Last Trade
May 12, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$214k 23,802 shares
$9.00
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $23.1M 1,162,500 shares
Last Trade
May 11, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$972k 106,698 shares
$9.11
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $2.12M 106,698 shares
Last Trade
May 11, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$972k 106,698 shares
$9.11
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $0 0 shares
Last Trade
May 11, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$982k 106,698 shares
$9.20
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $24.8M 1,250,000 shares
Last Trade
Jan 14, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$293k 19,581 shares
$14.97
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$294k 19,581 shares
$15.03
$19.86
Trillium Therapeutics
Trillium Therapeutics TRIL
President And CEO
Holding Value $389k 19,581 shares
Last Trade
Jan 14, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$293k 19,581 shares
$14.97
$19.86

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up